Drug Repurposing for Drug Development in StrokeFAGAN, Susan C.Pharmacotherapy. 2010, Vol 30, Num 7, issn 0277-0008, 51S-54S, 2Article

OLD DRUGS AND NEW TRICKS: UPDATE ON STROKE THERAPEUTICSFAGAN, Susan C.Pharmacotherapy. 2010, Vol 30, Num 7, issn 0277-0008, 23 p., 2Serial Issue

Repurposing an Old Drug to Improve the Use and Safety of Tissue Plasminogen Activator for Acute Ischemic Stroke: MinocyclineHESS, David C; FAGAN, Susan C.Pharmacotherapy. 2010, Vol 30, Num 7, issn 0277-0008, 55S-61S, 2Article

Targeting the Brain: Neuroprotection and Neurorestoration in Ischemic StrokeSAVER, Jeffrey L.Pharmacotherapy. 2010, Vol 30, Num 7, issn 0277-0008, 62S-69S, 2Article

Angiogenesis A Harmonized Target for Recovery After StrokeERGUL, Adviye; ALHUSBAN, Ahmed; FAGAN, Susan C et al.Stroke (1970). 2012, Vol 43, Num 8, pp 2270-2274, issn 0039-2499, 5 p.Article

Oxidative stress and cardiovascular disease : Antioxidants and unresolved issuesSACHIDANANDAM, Kamakshi; FAGAN, Susan C; ERGUL, Adviye et al.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 2, pp 115-132, issn 0897-5957, 18 p.Article

Role of angiotensin-converting-enzyme inhibitors in stroke preventionFAGAN, Susan C; LEE, Linda A; HESS, David C et al.American journal of health-system pharmacy. 2003, Vol 60, Num 8, pp 788-793, issn 1079-2082, 6 p.Article

Adaptive Cerebral Neovascularization in a Model of Type 2 DiabetesWEIGUO LI; PRAKASH, Roshini; KELLY-COMBS, Aisha I et al.Diabetes (New York, NY). 2010, Vol 59, Num 1, pp 228-235, issn 0012-1797, 8 p.Article

Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetesWEIGUO LI; KELLY-COBBS, Aisha I; MEZZETTI, Erin M et al.Canadian journal of physiology and pharmacology. 2010, Vol 88, Num 8, pp 788-795, issn 0008-4212, 8 p.Article

Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodelingELGEBALY, Mostafa M; PRAKASH, Roshini; WEIGUO LI et al.Journal of cerebral blood flow and metabolism. 2010, Vol 30, Num 12, pp 1928-1938, issn 0271-678X, 11 p.Article

Atopic dermatitis is associated with a decrement in health-related quality of lifeKIEBERT, Gwendoline; SORENSEN, Sonja V; REVICKI, Dennis et al.International journal of dermatology. 2002, Vol 41, Num 3, pp 151-158, issn 0011-9059Article

Vascularization Pattern After Ischemic Stroke Is Different in Control Versus Diabetic Rats: Relevance to Stroke RecoveryPRAKASH, Roshini; WEIGUO LI; ZHI QU et al.Stroke (1970). 2013, Vol 44, Num 10, pp 2875-2882, issn 0039-2499, 8 p.Article

Minocycline for short-term neuroprotectionELEWA, Hazem E; HILALI, Hend; HESS, David C et al.Pharmacotherapy. 2006, Vol 26, Num 4, pp 515-521, issn 0277-0008, 7 p.Article

Targets for vascular protection after acute ischemic strokeFAGAN, Susan C; HESS, David C; HOHNADEL, Elizabeth J et al.Stroke (1970). 2004, Vol 35, Num 9, pp 2220-2225, issn 0039-2499, 6 p.Article

Treatment of Fever After Stroke: Conflicting EvidenceWROTEK, Sylwia E; KOZAK, Wieslaw E; HESS, David C et al.Pharmacotherapy. 2011, Vol 31, Num 11, pp 1085-1091, issn 0277-0008, 7 p.Article

Vascular Protection to Increase the Safety of Tissue Plasminogen Activator for Stroke : The Blood Brain Barrier in StrokeISHRAT, Tauheed; SOLIMAN, Sahar; WEIHUA GUAN et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 25, pp 3677-3684, issn 1381-6128, 8 p.Article

Diverse Effects of Statins on Angiogenesis: New Therapeutic AvenuesELEWA, Hazem F; EL-REMESSY, Azza B; SOMANATH, Payaningal R et al.Pharmacotherapy. 2010, Vol 30, Num 2, pp 169-176, issn 0277-0008, 8 p.Article

Clinical Experience With Three-Factor Prothrombin Complex Concentrate to Reverse Warfarin Anticoagulation in Intracranial HemorrhageSWITZER, Jeffrey A; ROCKER, Jody; MOHORN, Phillip et al.Stroke (1970). 2012, Vol 43, Num 9, pp 2500-2502, issn 0039-2499, 3 p.Article

Association of serial biochemical markers with acute ischemic stroke : The National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator stroke studyJAUCH, Edward C; LINDSELL, Christopher; BRODERICK, Joseph et al.Stroke (1970). 2006, Vol 37, Num 10, pp 2508-2513, issn 0039-2499, 6 p.Article

Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotectionFAGAN, Susan C; EDWARDS, David J; BORLONGAN, Cesar V et al.Experimental neurology (Print). 2004, Vol 186, Num 2, pp 248-251, issn 0014-4886, 4 p.Article

Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke : A Canadian healthcare perspectiveSINCLAIR, Shannon E; FRIGHETTO, Luciana; LOEWEN, Peter S et al.PharmacoEconomics (Auckland). 2001, Vol 19, Num 9, pp 927-936, issn 1170-7690Article

Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki ratsWEIGUO LI; ZHI QU; PRAKASH, Roshini et al.Brain research. 2013, Vol 1541, pp 106-114, issn 0006-8993, 9 p.Article

Angiotensin receptor blockers and angiogenesis: clinical and experimental evidenceWILLIS, Lauren M; EL-REMESSY, Azza B; SOMANATH, Payaningal R et al.Clinical science (1979). 2011, Vol 120, Num 7-8, pp 307-319, issn 0143-5221, 13 p.Article

Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding StudyFAGAN, Susan C; WALLER, Jennifer L; NICHOLS, Fenwick T et al.Stroke (1970). 2010, Vol 41, Num 10, pp 2283-2287, issn 0039-2499, 5 p.Article

Clinical deterioration following improvement in the NINDS rt-PA Stroke TrialGROTTA, James C; WELCH, K. M. A; FAGAN, Susan C et al.Stroke (1970). 2001, Vol 32, Num 3, pp 661-668, issn 0039-2499Article